CorMedix Inc. - 8-K Filing
CorMedix Inc. filed to disclose that the U.S. Court of Appeals for the Federal Circuit affirmed a district court ruling in favor of CorMedix's subsidiary, Melinta Therapeutics, finding Nexus Pharmaceuticals' generic minocycline product infringes two patents covering MINOCIN® for Injection and rejecting Nexus’ invalidity challenge. (Items: 7.01 Regulation FD Disclosure On June 8, 2026, CorMedix, Inc, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)
Tickers: $CRMD